AN OPEN-LABEL, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL GROUP, MULTICENTRE, PHASE 3 STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF PA21 COMPARED WITH SEVELAMER CARBONATE FOLLOWED BY A RANDOMIZED COMPARISON OF PA21 MAINTENANCE DOSE VERSUS
Principal Investigator(s)
Qunibi,Wajeh Y
Funded by
VIFOR PHARMA LTD.
Research Start Date
Status
Inactive